The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Therapeutic Plasma Exchange Market In 2026 And What Value Is Projected For 2030?
The therapeutic plasma exchange market size has experienced significant growth in recent years. This market is anticipated to increase from $1.61 billion in 2025 to $1.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Several factors contributed to its historical growth, including increased diagnosis of autoimmune disorders, expansion of hospital transfusion services, the availability of centrifugation-based technologies, growing clinician familiarity with apheresis procedures, and the adoption of standardized treatment protocols.
The therapeutic plasma exchange market is projected to experience robust expansion over the coming years. This market is set to reach $2.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is primarily driven by an escalating demand for advanced autoimmune therapies, the wider uptake of membrane separation technology, the expansion of outpatient apheresis services, increased investment in blood purification technologies, and a greater emphasis on personalized immunological treatments. Key developments expected during this forecast period encompass the increasing integration of automated plasma exchange systems, the expanding application of tpe in neurological disorders, a surging requirement for high-efficiency separation technologies, the enlargement of hospital-based apheresis units, and a heightened focus on ensuring treatment safety and thorough monitoring.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
What Drivers Are Influencing The Therapeutic Plasma Exchange Market?
The increasing occurrence of hematological disorders is anticipated to fuel the expansion of the therapeutic plasma exchange market in the future. These conditions, also known as blood disorders, are health issues impacting the blood and its producing tissues, such as the bone marrow, lymph nodes, and spleen. The rise in hematological disorders is attributed to elements like genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) finds application in managing hematological disorders by eliminating harmful substances from the plasma, including autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, which helps reduce the severity of the illness and enhance patient results. An illustration of this trend is found in a July 2024 report by Cancer Research UK, a UK-based charity, which projects that the average number of new Hodgkin lymphoma cases annually in the UK will rise from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. Consequently, the widespread incidence of hematological disorders is propelling the growth of the therapeutic plasma exchange market.
What Are The Key Segments Of The Therapeutic Plasma Exchange Market?
The therapeutic plasma exchange market covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users
Subsegments:
1) By Therapeutic Plasma Exchange (TPE): Manual TPE, Automated TPE
2) By Double Filtered Plasmapheresis (DFPP): Single-Stage DFPP, Multi-Stage DFPP
What Trends Are Affecting The Expansion Of The Therapeutic Plasma Exchange Market?
Leading companies in the therapeutic plasma exchange market are concentrating on advancing automation, enhancing device safety, and boosting system efficiency to increase clinical adoption and streamline operational processes. Automation refers to the reliance on systems and technology to perform tasks automatically without the need for continuous human oversight. For instance, in November 2024, Terumo BCT, a US-based medical device company, introduced software update V12.1 for its flagship Spectra Optia Apheresis System. This update improves usability, strengthens cybersecurity, and optimizes workflow, including features like automatic pump pause during single needle exchange and alarm mitigation. The system effectively supports therapeutic plasma exchange with a mean plasma removal efficiency of 87 %, a minimal extracorporeal volume of 141 mL, and only 1.0 % median platelet loss. This progression towards sophisticated automation and improved device safety is increasing the uptake of TPE in hospitals and specialty clinics; however, significant capital costs and the necessity for trained personnel continue to restrict its adoption in settings with limited resources.
Who Are The Leading Companies Operating In The Therapeutic Plasma Exchange Market?
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.
Read the full therapeutic plasma exchange market report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Therapeutic Plasma Exchange Market?
North America was the largest region in the therapeutic plasma exchange market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Therapeutic Plasma Exchange Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp
Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2026, By The Business Research Company
Convalescent Plasma Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
Plasma Protein Therapeutics Global Market Report
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report
Blood Plasma Derivatives Global Market Report
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model